Re-assessing the risks of drug-induced arrhythmias during drug discovery
Drug Discovery World
AUGUST 15, 2023
However, many other drugs exhibit a more complex multichannel pharmacology 7 , which is much harder to interpret and cannot be easily modelled by screening against a single ion channel. Current Pharmaceutical Design, 12(4): 397- 406 Rassmussen et al. Dr Jack Scannell is CEO of Etheros Pharmaceuticals. Scannell & Bosley.
130 
Let's personalize your content